BRCA1 in hormone-responsive cancers.

Eliot M Rosen,Saijun Fan,Richard G Pestell,Itzhak D Goldberg

DOI: https://doi.org/10.1016/j.tem.2003.08.001

2003-01-01

Abstract:Mutations of the breast cancer susceptibility gene BRCA1 are linked to hereditary early onset breast and breast–ovarian cancer syndromes. These mutations confer an increased risk for other hormone-dependent cancers, including those of the uterus, cervix and prostate. BRCA1 expression is decreased or absent in a significant proportion of sporadic breast and ovarian cancers, suggesting a wider role in these tumor types. Multiple functions for BRCA1 have been identified, including roles in DNA repair, cell-cycle progression and apoptosis. These functions are consistent with a tumor suppressor activity, but they do not explain why BRCA1 mutation carriers develop hormone-responsive cancer types. Recent studies indicate that BRCA1 interacts with and regulates the activity of estrogen receptor α (ERα) and the androgen receptor. Its expression is regulated by carcinogens and anticarcinogens that modulate ERα signaling, suggesting a molecular linkage between BRCA1 and hormone-responsive cancers.